Platelet P2Y12 receptor inhibition by thienopyridines: status and future

By Porto Italo   Giubilato Simona   De Maria Giovanni Luigi   Biasucci Luigi Marzio   Crea Filippo  

Expert Opinion on Investigational Drugs, Vol. 18, Iss. 9, 2009-09 ,pp. : 1317-1332

Informa Healthcare

Access to resources Recommend Favorite

Prasugrel: a novel platelet ADP P2Y₁₂ receptor antagonist. A review on its mechanism of action and clinical development

By Angiolillo Dominick J   Suryadevara Siva   Capranzano Piera   Bass Theodore A  

Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 16, 2008-11 ,pp. : 2893-2900

Informa Healthcare

Access to resources Recommend Favorite

Biology and Pharmacology of the Platelet P2Y12 Receptor

By  

Current Pharmaceutical Design, Vol. 12, Iss. 10, 2006-04 ,pp. : 1255-1259

Bentham Science Publishers

Access to resources Recommend Favorite

Inhibition of platelet function by administration of MRS2179, a P2Y 1 receptor antagonist

By Baurand A.   Raboisson P.   Freund M.   Leon C.   Cazenave J.-P.   Bourguignon J.-J.   Gachet C.  

European Journal of Pharmacology, Vol. 412, Iss. 3, 2001-02 ,pp. : 213-221

Elsevier

Access to resources Recommend Favorite

Oral Antiplatelet Therapy for Acute Coronary Syndromes: Aspirin, P2Y12 Inhibition and Thrombin Receptor Antagonists

By  

Current Drug Targets, Vol. 12, Iss. 12, 2011-11 ,pp. : 1805-1812

Bentham Science Publishers

Access to resources Recommend Favorite